Table 3 Adverse events for patients with curative intent only
Adverse events | Age >75 years (n = 24) | Age ≤75 years (n = 39) | p value |
|---|---|---|---|
Dyspahgia (CTCAE) | 0.187 | ||
0° (%) | 0.0 | 15.4 | |
I° (%) | 54.2 | 43.6 | |
II° (%) | 33.3 | 20.5 | |
III° (%) | 12.5 | 17.9 | |
IV (%) | 0.0 | 2.6 | |
Leukopenia (CTCAE) | 0.157 | ||
0° (%) | 33.3 | 26.3 | |
I° (%) | 12.5 | 18.4 | |
II° (%) | 41.7 | 26.3 | |
III° (%) | 8.3 | 29.0 | |
IV (%) | 4.2 | 0.0 | |
Anemia (CTCAE) | 0.061 | ||
0° (%) | 0.0 | 17.9 | |
I° (%) | 62.5 | 38.5 | |
II° (%) | 33.3 | 41.0 | |
III° (%) | 4.2 | 2.6 | |
Thrombocytopenia (CTCAE) | 0.958 | ||
0° (%) | 29.2 | 34.3 | |
I° (%) | 58.3 | 51.4 | |
II° (%) | 12.5 | 11.4 | |
III° (%) | 0.0 | 0.0 | |
IV (%) | 0.0 | 2.9 | |